POST Online Media Lite Edition


Roche acquires Stratos Genomics

Christian Fernsby |
Roche announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer.

Article continues below


The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX™).

The Roche nanopore sequencer, once developed, will utilise a novel approach that combines electronic and biological components to sequence DNA for fast, flexible and cost-effective clinical diagnostic testing.

Stratos Genomics will continue operations in Seattle, Washington, U.S.

Financial details of the agreement were not disclosed.

What to read next

Netherlands has confidence in Roche commitments to help solve problems with test materials
Roche to invest 450 million Swiss Francs in China
Roche to acquire Santaris Pharma